Efficacy and safety of Chinese herbal medicine granules plus chemotherapy in patients with EGFR-mutated advanced lung adenocarcinoma post-progression on first-line EGFR-TKI: study protocol for a multicenter, double-blind, randomized controlled trial

Authors

Wenxiao Yang (ORCID: https://orcid.org/0009-0007-6953-7358)
Lijing Jiao (ORCID: https://orcid.org/0000-0002-6064-4946)
Jialin Yao (ORCID: https://orcid.org/0000-0001-8321-9793)
Xuanting Ye
Guanjin Wu
Ling Xu (ORCID: https://orcid.org/0009-0000-3422-7623)
Lingzi Su (ORCID: https://orcid.org/0000-0001-9300-9853)
Yabin Gong (ORCID: https://orcid.org/0000-0002-6811-101X)
Yizhao Du (ORCID: https://orcid.org/0000-0002-1361-4998)

Institutions

Shanghai University of Traditional Chinese Medicine (CN)
Yueyang Hospital (CN)

Publication Details

Journal: BMC Complementary Medicine and Therapies
Published: 2025-11-19
DOI: https://doi.org/10.1186/s12906-025-05037-z
Primary Topic: Lung Cancer Treatments and Mutations
Type: article
Field-Weighted Citation Impact: 0.00

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Efficacy and safety of Chinese herbal medicine granules plus chemotherapy in patients with EGFR-mutated advanced lung adenocarcinoma post-progression on first-line EGFR-TKI: study protocol for a multicenter, double-blind, randomized controlled trial

Wenxiao Yang, Lijing Jiao, Jialin Yao, Xuanting Ye et al.

Nov 19, 2025

BMC Complementary Medicine and Therapies

Lung Cancer Treatments and Mutations

article

Efficacy and safety of Chinese herbal medicine granules plus chemotherapy in patients with EGFR-mutated advanced lung adenocarcinoma post-progression on first-line EGFR-TKI: study protocol for a multicenter, double-blind, randomized controlled trial

Wenxiao Yang, Lijing Jiao, Jialin Yao, Xuanting Ye, Guanjin Wu, Ling Xu, Lingzi Su, Yabin Gong, Yizhao Du

November 19, 2025article en

Abstract

No abstract available for this paper.

BMC Complementary Medicine and TherapiesVol. 25(1)

Shanghai University of Traditional Chinese Medicine (CN), Yueyang Hospital (CN)

Openalex Percentile: Top 49%

Lung Cancer Treatments and Mutations

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Efficacy and safety of Chinese herbal medicine granules plus chemotherapy in patients with EGFR-mutated advanced lung adenocarcinoma post-progression on first-line EGFR-TKI: study protocol for a multicenter, double-blind, randomized controlled trial — Wenxiao Yang, Lijing Jiao, et al. · BMC Complementary Medicine and Therapies (2025) | TGRS Research Map | TGRS